RCUS - Arcus Biosciences - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

RCUS is currently covered by 11 analysts with an average price target of $40.67. This is a potential upside of $22.46 (123.34%) from yesterday's end of day stock price of $18.21.

Arcus Biosciences's activity chart (see below) currently has 54 price targets and 69 ratings on display. The stock rating distribution of RCUS is 90.63% BUY and 9.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.65% with an average time for these price targets to be met of 209.92 days.

Highest price target for RCUS is $70, Lowest price target is $23, average price target is $40.67.

Most recent stock forecast was given by ROBYN KARNAUSKAS from TRUIST on 25-Mar-2024. First documented stock forecast 09-Apr-2018.

Currently out of the existing stock ratings of RCUS, 29 are a BUY (90.63%), 3 are a HOLD (9.38%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

50

$31.79 (174.57%)

50

3 days ago

4/10 (40%)

$33.53 (203.58%)

359

Buy

30

$11.79 (64.74%)

30

1 months 6 days ago

3/9 (33.33%)

$10.33 (52.52%)

458

Buy

42

$23.79 (130.64%)

51

1 months 27 days ago

5/11 (45.45%)

$26.28 (167.18%)

186

Buy

35

$16.79 (92.20%)

38

4 months 15 days ago

0/3 (0%)

$21.57 (160.61%)

Buy

36

$17.79 (97.69%)

48

4 months 20 days ago

0/2 (0%)

$19.99 (124.86%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCUS (Arcus Biosciences) average time for price targets to be met?

On average it took 209.92 days on average for the stock forecasts to be realized with a an average price target met ratio 29.65

Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?

Robert Driscoll works at WEDBUSH and has 11 price targets and 7 ratings on RCUS

Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?

Kaveri Pohlman with highest potential upside - $50.9

Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?

Geoffrey Porges with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?